Efficacy of Vedolizumab Induction and Maintenance Therapy in Patients With Ulcerative Colitis, Regardless of Prior Exposure to Tumor Necrosis Factor Antagonists-Reference-Cited by-同舟云学术

Efficacy of Vedolizumab Induction and Maintenance Therapy in Patients With Ulcerative Colitis, Regardless of Prior Exposure to Tumor Necrosis Factor Antagonists

Published:2017-02 Issue:2 Volume:15 Page:229-239.e5
ISSN:1542-3565
Container-title:Clinical Gastroenterology and Hepatology
language:en
Short-container-title:Clinical Gastroenterology and Hepatology

Author:

Feagan Brian G.,Rubin David T.^ORCID,Danese Silvio,Vermeire Severine,Abhyankar Brihad,Sankoh Serap,James Alexandra,Smyth Michael

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference38 articles.

1. Ulcerative colitis;Danese;N Engl J Med,2011

2. Infliximab for induction and maintenance therapy for ulcerative colitis;Rutgeerts;N Engl J Med,2005

3. Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis;Sandborn;Gastroenterology,2012

4. Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis;Sandborn;Gastroenterology,2014

5. Subcutaneous golimumab maintains clinical response in patients with moderate-to-severe ulcerative colitis;Sandborn;Gastroenterology,2014

Cited by 172 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Old and New Biologics and Small Molecules in Inflammatory Bowel Disease: Anti Integrins;The Korean Journal of Gastroenterology;2024-08-25

2. Risankizumab for Ulcerative Colitis;JAMA;2024-07-22

3. Impact of Prior Biologic or Janus Kinase Inhibitor Therapy on Efficacy and Safety of Etrasimod in the ELEVATE UC 52 and ELEVATE UC 12 Trials;Journal of Crohn's and Colitis;2024-06-15

4. Approach to loss of response to advanced therapies in inflammatory bowel disease;World Journal of Gastroenterology;2024-06-14

5. Aktualisierte S3-Leitlinie Colitis ulcerosa (Version 6.2);Zeitschrift für Gastroenterologie;2024-05